Bioscience Animal Health Public Company Limited (BIS_BIOSCIENCE ANIMAL HEALTH) Aktie

Bioscience Animal Health Public Company Limited, together with its subsidiaries, manufactures, imports, and distributes pharmaceutical supplies, devices, equipment, and products for livestock and companion animals in Thailand and internationally. The company offers antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. In addition, the company offers farm production consultant; disease prevention and monitoring; serological diagnostic; farm biosecurity and sanitation; raw material, feed chemical, physical, and mycotoxin analysis; feed formulation; repacking and remixing and OEM Product; and farm human resource and training services. Further, it provides animal health products; nutrition products; diagnostic products, such as test kits and diagnostic medical devices; consulting services about testing method, installation, and laboratory protocol; complete feed products; ingredient products; and animal carcass incinerators. The company serves feed mills, integrated farms, agents, veterinary hospitals and clinics, pet shops, and modern trade and e-commerce customers. It exports its products. Bioscience Animal Health Public Company Limited was incorporated in 2004 and is headquartered in Nonthaburi, Thailand.